Stoke Therapeutics, Inc. (STOK)
29.00
-1.01
(-3.37%)
USD |
NASDAQ |
Jun 08, 16:00
29.15
+0.15
(+0.52%)
Pre-Market: 09:10
Stoke Therapeutics Market Cap : 1.805B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.762B |
| Agenus, Inc. | 120.96M |
| Amgen, Inc. | 186.59B |
| BioCryst Pharmaceuticals, Inc. | 2.141B |
| Imunon, Inc. | 7.885M |
Market Cap Related Metrics
| PS Ratio | 53.88 |
| Price to Book Value | 4.571 |
| Price | 29.00 |
| Earnings Yield | -9.80% |